Patents by Inventor Jane E. Ennis

Jane E. Ennis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150246079
    Abstract: Described herein is a method for modulating an immune reaction between lymphocytes and a body recognized by the lymphocytes as foreign. The method exploits the immunomodulating activity of a new class of progenitor cells termed HUCPVCs derived from the perivascular region of human umbilical cord. The method can also employ soluble factors exuded by cultured HUCPVCs. The method is useful to treat immune disorders including graft versus host disease, autoimmune disorders, and the like.
    Type: Application
    Filed: November 26, 2014
    Publication date: September 3, 2015
    Inventors: John E. DAVIES, Jane E. ENNIS, Alejandro GOMEZ-ARISTIZABAL, Dolores BAKSH
  • Patent number: 8790923
    Abstract: Viable progenitor cells are extracted from frozen umbilical cord tissue. In embodiments, the umbilical cord tissue is a blood vessel bearing perivascular Wharton's jelly, and the extracted progenitor cells are HUCPVCs.
    Type: Grant
    Filed: September 28, 2012
    Date of Patent: July 29, 2014
    Inventors: Jane E. Ennis, Rahul Sarugaser, John E. Davies
  • Publication number: 20130315952
    Abstract: The invention provides compositions and methods for the prophylaxis or treatment of diseases or disorders in a subject (e.g., a mammal, such as a human) including, e.g., diseases or disorders caused by biological agents, autoimmune diseases, and cancer. The compositions include a delivery vector (e.g., a viral vector, such as an Ad5 vector) encoding an interferon (e.g., IFN-?), and are provided to the subject by, e.g., intranasal or pulmonary administration.
    Type: Application
    Filed: November 13, 2012
    Publication date: November 28, 2013
    Applicant: Defyrus, Inc.
    Inventors: Jeffrey D. Turner, Jane E. Ennis
  • Publication number: 20130023049
    Abstract: Viable progenitor cells are extracted from frozen umbilical cord tissue. In embodiments, the umbilical cord tissue is a blood vessel bearing perivascular Wharton's jelly, and the extracted progenitor cells are HUCPVCs.
    Type: Application
    Filed: September 28, 2012
    Publication date: January 24, 2013
    Inventors: Jane E. ENNIS, Rahul SARUGASER, John E. DAVIES
  • Patent number: 8309531
    Abstract: The invention provides compositions and methods for the prophylaxis or treatment of diseases or disorders in a subject (e.g., a mammal, such as a human) including, e.g., diseases or disorders caused by biological agents, autoimmune diseases, and cancer. The compositions include a delivery vector (e.g., a viral vector, such as an Ad5 vector) encoding an interferon (e.g., IFN-?), and are provided to the subject by, e.g., intranasal or pulmonary administration.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: November 13, 2012
    Assignee: Defyrus, Inc.
    Inventors: Jeffrey D. Turner, Jane E. Ennis
  • Publication number: 20110000480
    Abstract: The invention provides compositions and methods for the prophylaxis or treatment of diseases or disorders in a subject (e.g., a mammal, such as a human) including, e.g., diseases or disorders caused by biological agents, autoimmune diseases, and cancer. The compositions include a delivery vector (e.g., a viral vector, such as an Ad5 vector) encoding an interferon (e.g., IFN-?), and are provided to the subject by, e.g., intranasal or pulmonary administration.
    Type: Application
    Filed: June 9, 2010
    Publication date: January 6, 2011
    Inventors: Jeffrey D. Turner, Jane E. Ennis